Donor Characteristics and Regional Differences in the Utilization of HCV-Positive Donors in Liver Transplantation
Open Access
- 1 December 2020
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA Network Open
- Vol. 3 (12) , e2027551
Abstract
Despite an increase in the number of liver transplants (LTs) performed in the United States, the rate at which patients are placed on the waitlist continues to surpass the increased number of transplants, creating a significant mismatch between organ supply and demand.1 The use of hepatitis C virus (HCV)–positive organs has been widely adopted as one of the solutions to the major organ shortage by increasing the donor pool.2 Although HCV infection is estimated to affect 1% to 2% of the general US population, this risk is higher (3%-18%) among organ donors with increased risk as defined by the Public Health Service.3 In light of the ongoing opioid epidemic and the associated rise in drug overdose deaths, the number of Public Health Service “increased risk” HCV-positive organs available has been increasing rapidly.4,5Keywords
This publication has 33 references indexed in Scilit:
- Disparities in Absolute Denial of Modern Hepatitis C Therapy by Type of InsuranceClinical Gastroenterology and Hepatology, 2016
- Disparate access to treatment regimens in chronic hepatitis C patients: data from the TRIO networkJournal of Viral Hepatitis, 2016
- Increases in Drug and Opioid Overdose Deaths — United States, 2000–2014MMWR. Morbidity and Mortality Weekly Report, 2016
- Evolution of indications and results of liver transplantation in Europe. A report from the European Liver Transplant Registry (ELTR)Journal of Hepatology, 2012
- Estimated Risk of Human Immunodeficiency Virus and Hepatitis C Virus Infection among Potential Organ Donors from 17 Organ Procurement Organizations in the United StatesAmerican Journal of Transplantation, 2011
- Liver allografts from hepatitis C positive donors can offer good outcomes in hepatitis C positive recipients: a US National Transplant Registry analysisTransplant International, 2010
- The Biopsied Donor Liver: Incorporating Macrosteatosis Into High-Risk Donor AssessmentLiver Transplantation, 2010
- Social Stigmatization and Hepatitis C Virus InfectionJournal of Clinical Gastroenterology, 2006
- Characteristics Associated with Liver Graft Failure: The Concept of a Donor Risk IndexAmerican Journal of Transplantation, 2006
- The outcome of liver grafts procured from hepatitis C-positive donorsTransplantation, 2002